Announcements Trials

Browse Landscape

Phase

Phase 2 94 Phase 1 82 Phase 1/2 41 Phase 3 10 Phase NA 9 Phase EARLY_PHASE1 9 Phase 4 5 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 117 Neoplasms 101 Prostatic Neoplasms 76 Carcinoma, Non-Small-Cell Lung 75 Colorectal Neoplasms 73 Carcinoma, Hepatocellular 67 Leukemia, Myeloid, Acute 58 Stomach Neoplasms 52 Neoplasm Metastasis 50 Lung Neoplasms 48 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Pancreatic Neoplasms 40 Recurrence 36 Head and Neck Neoplasms 32 Rectal Neoplasms 30 Colonic Neoplasms 30 Leukemia 29 Multiple Myeloma 28 Ovarian Neoplasms 26 Lymphoma 25 Squamous Cell Carcinoma of Head and Neck 24 Hematologic Neoplasms 23 Melanoma 22 Urinary Bladder Neoplasms 20 Liver Neoplasms 20 Polycystic Ovary Syndrome 19 Myelodysplastic Syndromes 19 Lymphoma, Large B-Cell, Diffuse 19 Esophageal Neoplasms 19 Uterine Cervical Neoplasms 16

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Lymphoma, T-Cell × Clear all

NCT00877656 2024-03-18

HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma

Emergent BioSolutions

Phase 2/3 Completed

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡